Medical network - on April 5, proprietary Chinese medicine name is not one size fits all, old or avoid renamed crisis. 

 

Registered in January this year, in order to strengthen management, to further standardize the naming of proprietary Chinese medicine, reflects the characteristics of traditional Chinese medicine, respect the culture and traditions, the state food and drug supervision bureau released the proprietary Chinese medicine generically named technology guidelines (draft) ", a stone up, for all kinds of articles have appeared in the net side, have fun, have to worry about, also have disappointed. 

 

From the starting point of the policy is in order to standardize the naming of proprietary Chinese medicine, such as must not contain any hint and exaggerated effect of the content, such as "strong" "available", "drive", "secret", etc., these wrong, and explicitly mentioned drug name cannot contain "treasure", "spirit" and "fine" and so on, also must not contain any person names, place names, etc. 

 

So, people are worried about "wind", "yunnan baiyao" and other common drugs are changed, not only bring huge economic losses due to changed its name to the enterprise, will also bring so much inconvenience to consumers. 

 

However, according to xinhua, recently, head of the state general administration of eating drug safety medicine change registration division is proprietary Chinese medicine named the new rules, said the regulation does not involve carrying the old name of drug of traditional culture of traditional Chinese medicine, such as yunnan baiyao, tongrentang drugs out of place in the name. And made it clear that those who need to change name of proprietary Chinese medicine drugs also offer certain transition, drug firms in transition can be printed at the same time on the medicine package old drug name and new name, after consumer habits change into new drug name again. 

 

▍ 50 old drug firms, 685 varieties or from the name 

 

The author through the ministry of commerce "finalists information management network" to spend a lot of effort to finalists pharmaceutical companies to screen out then contrast the CFDA approval database found that approximately 48 pharmaceutical 685 varieties because it is old or from the name. 

 

The old pharmaceutical enterprises in our country and its related to or from renamed the number of varieties in the following table: 

 

 

 

 

Note: the data according to the ministry of commerce the old information management web site data compilation, due to the manual sorting, difficult to ensure the perfect information, the information for your reference. 

 

▍ received package "China time-honored brand" 

 

In February this year, the ministry of commerce and other 16 departments on guidance to promote the development of time-honored brand innovation "(hereinafter referred to as" guidance ") issued, 1128 enterprises will usher in the "China time-honored brand" policy package. 

 

Pharmaceutical enterprises with the title "China time-honored brand" usually has one or more protected varieties or Chinese materia medica confidential varieties, most of these varieties are exclusive varieties at the same time, in the market has high barriers, plus many departments jointly issued the "guidelines", put forward national policy tilt will give money and support. 

 

On March 9, in addition, according to the ministry of commerce spokesman Sun Jiwen in conference call including pharmaceutical enterprise of "China time-honored brand" enterprises to actively promote old varieties, quality, creates the brand, increase the supply capacity and quality, better meet the needs of the people's consumption upgrading. 

 

As for the old drug firms how to seize the development opportunity? 

 

Experts say: one is to promote fusion of old and new technology. Promote old pharmaceutical enterprises to actively introduce social capital, the traditional mode of operation and modern technology, especially the Internet, the Internet of things, big data, such as combination of modern information technology, the development of new products, to attract new customers, open up new markets; The second is to carry forward the cultural connotation, implement the old protection development project; 3 it is continuously optimized development environment of old, establish and improve the old files, strengthen self-discipline, strengthen intellectual property protection and policy support. The old drug firms nearly more than 700 varieties, or from the name, is the country of the embodiment of the intellectual property rights and policy support. 

 

P.S. finalists pharmaceutical companies and/or from the name list of proprietary Chinese medicine 

 

Note: the data according to the ministry of commerce finalists information management web site and the CFDA website data compilation, due to the manual sorting, difficult to ensure the perfect information, the information for your reference.